期刊
CLINICAL ENDOCRINOLOGY
卷 84, 期 5, 页码 729-735出版社
WILEY
DOI: 10.1111/cen.12872
关键词
-
资金
- Sigurd and Elsa Goljes Foundation
- Stockholm County Council
- Karolinska Institutet
ObjectiveGraves' disease (GD) is an autoimmune disease characterized by the presence of circulating autoantibodies against thyroid-stimulating hormone (TSH) receptor. Despite extensive research, the pathogenic mechanisms remain unclear. Immune responses associated with the disease may lead to cell activation/apoptosis and the release of microvesicles (MVs) into the circulation. MVs can display biological activities which may aggravate GD further. We studied immune mechanisms in GD by investigating the numbers and phenotype of circulating MVs in patients before and after antithyroid therapy with thiamazole. Patients and measurementsSamples were obtained from 15 patients with GD in the acute phase of hyperthyroidism and following 17-26 months treatment and 14 healthy controls. MVs from platelets, endothelial cells and monocytes exposing inflammation/activation markers (P-selectin, CD40 ligand, E-selectin and HMGB1) and MVs containing nuclear molecules were measured with flow cytometry. ResultsPatients had elevated baseline values of MVs (P < 0001 for all types of MVs), while the levels decreased during thiamazole treatment (P < 005 for all types of MVs). The majority of MV populations remained, however, significantly higher in patients after treatment compared to levels in controls. ConclusionsGD patients have elevated levels of MVs that carry molecules with potential biological activities. MVs are significantly reduced after antithyroid treatment with thiamazole but still higher compared to levels in healthy controls. Assessment of MV levels and pattern may therefore provide additional information on underlying immune disturbances not obtained by measurements of hormone levels alone.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据